Differential DNA methylation following chemotherapy for breast cancer is associated with lack of memory improvement at one year

Differential DNA methylation following chemotherapy for breast cancer is associated with lack of memory improvement at one year

The biological basis underlying cognitive dysfunction in women with early-stage breast cancer (BC) remains unclear, but could reflect gene expression changes that arise from the acquisition and long-term retention of soma-wide alterations in DNA methylation in response to chemotherapy. In this longi...

Full description

Bibliographic Details
Main Authors: Gee Su Yang, Xinlei Mi, Colleen K. Jackson-Cook, Angela R. Starkweather, Debra Lynch Kelly, Kellie J. Archer, Fei Zou, Debra E. Lyon
Format: Article
Language:English
Published: Taylor & Francis Group 2020-05-01
Series:Epigenetics
Subjects:
breast cancer
chemotherapy
epigenetics
dna methylation
chemo-brain
cognitive function
Online Access:http://dx.doi.org/10.1080/15592294.2019.1699695

Internet

http://dx.doi.org/10.1080/15592294.2019.1699695

Similar Items